Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma.
Persistent human papillomavirus infection (HPV) is recognized as an important etiologic factor for a subset of head and neck squamous cell carcinomas (SCC), especially those arising from the oropharynx. Whereas HPV16 accounts for the majority of HPV DNA-positive oropharyngeal SCC, infections with other mucosal high-risk HPV types are quite rare and biological data demonstrating their causal involvement are insufficient. Here we present the first case of an oropharyngeal SCC driven by HPV type 58. A 69-year-old Caucasian woman presented with an enlarged and firm left tonsil. A computed tomography scan showed a left tonsillar mass, extending to the soft palate and the glossotonsillar sulcus. The patient underwent extended radical tonsillectomy and ipsilateral selective neck dissection. Pathology confirmed an infiltrating, poorly differentiated SCC of the left tonsil with node metastasis (pT2N1). Adjuvant external beam radiation therapy (60 Grays (Gy)) was administered. After 1 year of follow-up, the patient is well with no evidence of cancer recurrence. HPV analyses of the tumor tissue by BSGP5+/6+ -PCR/MPG, targeting 51 mucosal HPV types, showed single positivity for HPV type 58. Presence of HPV58 E6*I RNA demonstrated biological activity of the virus in the tumor tissue, and presence of serum antibodies to HPV58 oncoproteins E6 and E7 indicated presence of an HPV58-driven cancer. Overexpression of cellular protein p16INK4a and reduced expression of pRb, two cellular markers for HPV-induced cell transformation, were observed. Exons 4-10 of TP53 showed no mutations or polymorphisms. The presence of HPV58 as single HPV infection in combination with a broad variety of direct and indirect markers of HPV transformation provides comprehensive evidence that this oropharyngeal SCC was driven by HPV58.
Lorena
L
Baboci
Paolo
P
Boscolo-Rizzo
Dana
D
Holzinger
Roberta
R
Bertorelle
Lorena
L
Biasini
Angelika
A
Michel
Markus
M
Schmitt
Giacomo
G
Spinato
Rossana
R
Bussani
Laia
L
Alemany
Giancarlo
G
Tirelli
Maria Cristina
MC
Da Mosto
Veneto Institute of Oncology IOV - IRCCS, Immunology and Molecular Oncology Unit, Via Gattamelata, 64, Padua 35128-I, Italy. annarosa.delmistro@ioveneto.it.
Annarosa
A
Del Mistro
Michael
M
Pawlita
D000368:Aged; D002277:Carcinoma / Q000209:etiology / Q000532:radiotherapy / Q000601:surgery / Q000821:virology*; D005260:Female; D006257:Head / Q000000981:diagnostic imaging; D006651:Histocytochemistry; D006801:Humans; D009959:Oropharyngeal Neoplasms / Q000209:etiology / Q000532:radiotherapy / Q000601:surgery / Q000821:virology*; D027383:Papillomaviridae / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000150:complications* / Q000821:virology; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics; D014057:Tomography, X-Ray Computed; D014068:Tonsillectomy
D012333:RNA, Messenger; D012367:RNA, Viral